p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-21
DOI
10.3389/fonc.2020.01252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Homeostasis of SLC4A11 protein is mediated by endoplasmic reticulum-associated degradation
- (2019) Susumu Hara et al. EXPERIMENTAL EYE RESEARCH
- p53 and metabolism: from mechanism to therapeutics
- (2018) Fernando M. Simabuco et al. Oncotarget
- Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1)
- (2017) Yixue Gu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Endostatin sensitizes p53-deficient non-small-cell lung cancer to genotoxic chemotherapy by targeting DNA-dependent protein kinase catalytic subunit
- (2017) Lin Jia et al. JOURNAL OF PATHOLOGY
- Loss of Uracil DNA Glycosylase Selectively Resensitizes p53-Mutant and -Deficient Cells to 5-FdU
- (2017) Yan Yan et al. MOLECULAR CANCER RESEARCH
- Targeting the MDM2–p53 Protein–Protein Interaction for New Cancer Therapy: Progress and Challenges
- (2017) Shaomeng Wang et al. Cold Spring Harbor Perspectives in Medicine
- p53 as guardian of the mitochondrial genome
- (2016) Ji-Hoon Park et al. FEBS LETTERS
- Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
- (2016) Gao Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- AKT/GSK3β Signaling in Glioblastoma
- (2016) Ewelina Majewska et al. NEUROCHEMICAL RESEARCH
- SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage
- (2016) Xuehui Hong et al. NUCLEIC ACIDS RESEARCH
- Regulation of Cellular Metabolism and Hypoxia by p53
- (2016) Timothy J. Humpton et al. Cold Spring Harbor Perspectives in Medicine
- p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis
- (2015) X. Wang et al. CANCER RESEARCH
- SIRT1/PGC1 -Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer
- (2015) T. T. Vellinga et al. CLINICAL CANCER RESEARCH
- Transcriptional Regulatory Circuits Controlling Brown Fat Development and Activation
- (2015) Patrick Seale DIABETES
- Overexpression of PGC-1α enhances cell proliferation and tumorigenesis of HEK293 cells through the upregulation of Sp1 and Acyl-CoA binding protein
- (2015) SUNG-WON SHIN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Circadian Rhythmicity of Active GSK3 Isoforms Modulates Molecular Clock Gene Rhythms in the Suprachiasmatic Nucleus
- (2015) Rachel C. Besing et al. JOURNAL OF BIOLOGICAL RHYTHMS
- P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway
- (2015) Ruipeng Song et al. International Journal of Surgery
- p53 attenuates AKT signaling by modulating membrane phospholipid composition
- (2015) Natalia Rueda-Rincon et al. Oncotarget
- p53 and mitochondrial function in neurons
- (2014) David B. Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents
- (2014) Minh Truong Do et al. FREE RADICAL BIOLOGY AND MEDICINE
- Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
- (2013) Rizwan Haq et al. CANCER CELL
- p53 Orchestrates the PGC-1α-Mediated Antioxidant Response Upon Mild Redox and Metabolic Imbalance
- (2012) Katia Aquilano et al. ANTIOXIDANTS & REDOX SIGNALING
- p53-PGC-1α Pathway Mediates Oxidative Mitochondrial Damage and Cardiomyocyte Necrosis Induced by Monoamine Oxidase-A Upregulation: Role in Chronic Left Ventricular Dysfunction in Mice
- (2012) Christelle Villeneuve et al. ANTIOXIDANTS & REDOX SIGNALING
- The F-box Protein FBXO44 Mediates BRCA1 Ubiquitination and Degradation
- (2012) Yunzhe Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis
- (2011) Pablo J Fernandez-Marcos et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- PGC-1 family coactivators and cell fate: Roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria–nucleus signalling
- (2011) Aleck W.E. Jones et al. MITOCHONDRION
- PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
- (2011) Nirmalya Sen et al. MOLECULAR CELL
- Telomere dysfunction induces metabolic and mitochondrial compromise
- (2011) Ergün Sahin et al. NATURE
- Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin
- (2010) Tilman Schneider-Poetsch et al. Nature Chemical Biology
- Dynamic regulation of PGC-1α localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response
- (2009) Rozalyn M. Anderson et al. AGING CELL
- Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome
- (2009) Daniel Finley Annual Review of Biochemistry
- PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
- (2009) Tatsuya Kawase et al. CELL
- Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target Effects
- (2009) Yama A. Abassi et al. CHEMISTRY & BIOLOGY
- Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway
- (2009) Peixin Dong et al. Molecular Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started